Harmony Biosciences Inc.

HRMY | NASDAQ

Price Alert Chart Builder DCF Calculator

$42.05

-$0.05 (-0.12%)

Sep 22, 2026, 11:54 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	868.45M	714.73M	582.02M	437.86M	305.44M	159.74M
Cost of Revenue	198.34M	156.82M	121.24M	83.48M	55.52M	27.74M
Gross Profit	670.11M	557.92M	460.79M	354.37M	249.92M	132M
Operating Income	208.47M	190.83M	192.03M	120.19M	87.53M	16.99M
Interest Income	21.92M	18.54M	14.73M	3.13M	224K	n/a
Pretax Income	215.06M	191.8M	173.4M	104.69M	37.43M	-36.94M
Net Income	158.69M	145.49M	128.85M	181.47M	34.6M	-36.94M
Selling & General & Admin	272.05M	221.27M	192.69M	163.3M	132.03M	95.57M
Research & Development	189.59M	145.83M	76.06M	70.89M	30.37M	19.45M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	461.64M	367.09M	268.76M	234.19M	162.39M	115.02M
Interest Expense	14.65M	17.5M	23.76M	18.8M	24.19M	28.22M
Selling & Marketing Expenses	119.51M	110.92M	97.4M	79.29M	68.12M	55.82M
Cost & Expenses	659.98M	523.91M	389.99M	317.67M	217.91M	142.76M
Income Tax Expense	56.38M	46.31M	44.54M	-76.78M	2.83M	n/a
Shares Outstanding (Basic)	57.49M	56.89M	59.47M	59.17M	57.53M	56.89M
Shares Outstanding (Diluted)	58.54M	57.87M	60.37M	61.1M	59.21M	57.85M
EPS (Basic)	2.76	2.56	2.17	3.07	0.60	-1.12
EPS (Diluted)	2.71	2.51	2.13	2.97	0.58	-1.10
EBITDA	255.05M	233.41M	221.51M	146.87M	80.46M	1.51M
EBIT	229.71M	209.3M	197.15M	123.48M	61.62M	-8.72M
Depreciation & Amortization	25.34M	24.11M	24.36M	23.39M	18.84M	10.24M